The mechanisms of acquired resistance to these therapies are currently unknown. CONCLUSIONS: inhibitors, and new therapeutic strategies are required to delay and overcome this drug resistance in patients with cancer.
⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:
Read Full Paper at OpenAlex